Cancer Center Seminar Series

photo of seminar

About the Seminar Series

Presented by Masonic Cancer Center, University of Minnesota this interdisciplinary seminar series provides a venue for basic-science and clinical researchers to hear about cutting-edge work in all areas of cancer. The series features invited speakers and MCC faculty with expertise in selected topics related to cancer. 

The 2020-2021 Seminar Series will be held via Zoom - Tuesdays 9-10 a.m.

Please use this URL to join:

Or join by phone:
Dial(for higher quality, dial a number based on your current location):
US: +1 651 372 8299 or 877 853 5257 (Toll Free) or 888 475 4499(Toll Free)
Meeting ID: 986 9271 3230
International numbers available:

Seminar presentations are recorded when possible and available to view on the MCC YouTube page.

For more information: 624-0653,

Upcoming Seminars

Bridging Pre-Clinical Drug Screening with Patient Molecular Profiles for Biomarker Discovery & Drug Repurposing - Sept. 29, 2020

September 29, 2020

R. Stephanie Huang, PhD
Associate Professor, Department of Experimental and Clinical Pharmacology
University of Minnesota

Title TBA - Oct. 6, 2020

October 6, 2020

Lindsey Sloan, MD, PhD
Assistant Professor, Department of Radiation Oncology
University of Minnesota

Cancer communication intervention and dissemination development for rural and urban contexts - Oct 13, 2020

October 13, 2020

Elisia Cohen, PhD
Professor, Hubbard School of Journalism and Mass Communication 
University of Minnesota

Host: Dorothy Hatsukami, PhD

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry - Oct. 20, 2020

October 20, 2020

Oliver Sartor, MD
Medical Director, Tulane Cancer Center
C. E. and Bernadine Laborde Professor of Cancer Research
Associate Dean for Oncology, Tulane University School of Medicine

Host: Jen Poynter, MPH, PhD

NCI Resources for Cancer Prevention Agent Development - Oct. 27, 2020

October 27, 2020

Mark Miller, PhD
Program Director Chemopreventive Agent Development Research Group 
Division of Cancer Prevention, National Cancer Institute

Host: Frank Ondrey, MD, PhD

Genome Instability and DNA Damage Tolerance Pathways - Nov. 3, 2020

November 3, 2020

Anja K. Bielinsky, PhD
Professor, Department of Biochemistry, Molecular Biology and Biophysics 
Associate Dean for Foundational Science, University of Minnesota Medical School 
Co-leader, Genetic Mechanisms of Cancer Program
Associate Director for Basic Shared Resources, Masonic Cancer Center

Title TBA - Nov. 10, 2020

November 10, 2020

Christopher Klebanoff, MD
Assistant attending and member, IOS-HOPP, MSKCC
Memorial Sloan Kettering Cancer Center

Host: Branden Moriarity, PhD and Beau Webber, PhD

TBA - Nov. 17, 2020

November 17, 2020


Thanksgiving Holiday Week – NO SEMINAR

November 24, 2020

Chemical Epigenetics Approaches for Developing Selective BRD4 Inhibitors as Novel Anti-Cancer and Anti-Inflammatory Agents - Dec. 1, 2020

December 1, 2020

William Pomerantz, PhD
McKnight Presidential Fellow 
Associate Professor of Chemistry
University of Minnesota

TBA - Dec. 8, 2020

December 8, 2020

Himisha Beltran, MD

Associate Professor of Medicine, Department of Medical Oncology

Dana Farber Cancer Institute

Host: Scott Dehm, PhD

TBA - Dec. 15, 2020

December 15, 2020